CG Oncology, Inc. (CGON)

57.03 +2.11 (+3.84%) USD  |  NASDAQ  |  Jun 11, 12:49
More

CG Oncology EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for CGON.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical EPS Diluted (Quarterly YoY Growth) Data

View and export this data back to 2023. Start Trial.
Date Value
March 31, 2026 --
December 31, 2025 --
September 30, 2025 --
June 30, 2025 --
March 31, 2025 --
Date Value
December 31, 2024 --
September 30, 2024 --
June 30, 2024 --
March 31, 2024 --
December 31, 2023 --

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Cogent Biosciences, Inc. Upgrade
Vera Therapeutics, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade